IQ 3;IQ3;[(E)-Indeno[1,2-b]quinoxalin-11-ylideneamino] furan-2-carboxylate;IQ-3
Cas No.
312538-03-7
分子式
C20N3O3H11
分子量
341.32
包装储存
Powder
-20°C
3 years
In solvent
-80°C
6 months
-20°C
1 month
生物活性
IQ-3 is a specific inhibitor of the c-Jun N-terminal kinase (JNK) family, with preference for JNK3. IQ-3 exhibits Kd values of 0.24 μM, 0.29 μM and 0.066 μM for JNK1, JNK2 and JNK3, respectively.
性状
Solid
IC50 & Target[1][2]
JNK3
0.066 μM (Kd)
JNK1
0.24 μM (Kd)
JNK2
0.29 μM (Kd)
CK1δ
0.56 μM (Kd)
PI3Kγ
0.43 μM (Kd)
MKNK2
1.2 μM (Kd)
体外研究(In Vitro)
IQ-3 exhibits IC50 of 2.2 μM (TNF-α in human monoMac-6 cells), 1.5 μM (IL-6 in human monoMac-6 cells), 4.7 μM (TNF-α in human PBMCs), 9.1 μM (IL-6 in human PBMCs) and 6.1 μM (NO in murine J774.A1), respectively.
IQ-3 exhibits an IC50 of 1.4 μM for inhibiting LPS-induced NF-κB/AP-1 transcriptional activity in human THP-1 Blue monocytic cells.
IQ-3 is indeed a competitive inhibitor for the ATP binding site of JNK3.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.